Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A prospective, multicenter, randomized, double-blind, placebo-controlled, 2-parallel group, Phase III study to compare efficacy and safety of masitinib at 9 mg/kg/day in combination with gemcitabine, to placebo in combination with gemcitabine, in treatment of patients with advanced/metastatic pancreatic cancer https://www.kusajili.fr:443/Trial/jU9tgch4o0qQbgaixegmXQ%24a-prospective-multicenter-randomized-double-blind-placebo-controlled-2-parallel-group-phase-iii-study-to-compare-efficacy-and-s
I have read and accept the terms of use of the site and the Privacy Policy
Send your message